These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8058185)

  • 21. The effects of calcium entry blockade on normal and ischemic ventricular diastolic function.
    Walsh RA
    Circulation; 1989 Dec; 80(6 Suppl):IV52-8. PubMed ID: 2688985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Influence of pacing site on myocardial transmural dispersion of repolarization in intact normal and dilated cardiomyopathy dogs].
    Bai R; Pu J; Liu N; Lu JG; Zhou Q; Ruan YF; Niu HY; Wang L
    Sheng Li Xue Bao; 2003 Dec; 55(6):722-30. PubMed ID: 14695492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Safety and tolerability of beta-blockers in severe cardiac decompensation from dilated cardiomyopathy].
    Sinagra G; Perkan A; Zecchin M; Di Lenarda A; Lardieri G; Rakar S; Secoli G; Pinamonti B; Camerini F
    G Ital Cardiol; 1995 Oct; 25(10):1255-63. PubMed ID: 8682221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?].
    Brilla CG; Schencking M; Scheer C; Rupp H
    Praxis (Bern 1994); 1997 Apr; 86(14):566-74. PubMed ID: 9198851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is left ventricular systolic dysfunction in hypertensive patients with heart failure normalized by long-term antihypertensive therapy?
    Hamada M; Ohtani T; Suzuki M; Lin M; Kobayashi T; Okayama H; Takezaki M; Hashida K; Abe M; Matsuoka H
    J Cardiol; 1993; 23(2):165-75. PubMed ID: 8176628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study.
    Izawa H; Murohara T; Nagata K; Isobe S; Asano H; Amano T; Ichihara S; Kato T; Ohshima S; Murase Y; Iino S; Obata K; Noda A; Okumura K; Yokota M
    Circulation; 2005 Nov; 112(19):2940-5. PubMed ID: 16275882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction.
    Kühl U; Pauschinger M; Schwimmbeck PL; Seeberg B; Lober C; Noutsias M; Poller W; Schultheiss HP
    Circulation; 2003 Jun; 107(22):2793-8. PubMed ID: 12771005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced right ventricular ejection fraction as a marker for idiopathic dilated cardiomyopathy compared with ischemic left ventricular dysfunction.
    La Vecchia L; Zanolla L; Varotto L; Bonanno C; Spadaro GL; Ometto R; Fontanelli A
    Am Heart J; 2001 Jul; 142(1):181-9. PubMed ID: 11431676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Vasodilator treatment of chronic heart failure].
    Woroszylska M
    Kardiol Pol; 1983; 26(10):741-51. PubMed ID: 6141316
    [No Abstract]   [Full Text] [Related]  

  • 30. [Calcium antagonists--their clinical use].
    Draganov V
    Vutr Boles; 1985; 24(2):29-36. PubMed ID: 3898584
    [No Abstract]   [Full Text] [Related]  

  • 31. Hemodynamic and electrophysiologic effects of first- and second-generation calcium antagonists.
    Vetrovec GW
    Am J Cardiol; 1994 Jan; 73(3):34A-38A. PubMed ID: 8310974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of calcium antagonists in the treatment of chronic heart failure.
    Parameshwar J; Poole-Wilson PA
    Eur Heart J; 1993 Jul; 14 Suppl A():38-44. PubMed ID: 8370361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in the management of chronic heart failure.
    Chatterjee K
    Prim Care; 1985 Mar; 12(1):117-42. PubMed ID: 3846305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium antagonists in cardiomyopathy.
    Richardson PJ
    Br J Clin Pract Suppl; 1988 Apr; 60():33-7. PubMed ID: 3151269
    [No Abstract]   [Full Text] [Related]  

  • 35. Arguments supporting the use of calcium antagonists in idiopathic dilated cardiomyopathy: theoretical considerations and clinical results.
    Figulla HR; Kreuzer H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S45-9. PubMed ID: 1707115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Severe hypertrophic myocardiopathy in newborn infants. Intra-erythrocyte calcium and the effect of lidoflazine, a calcium-channel inhibitor. Apropos of 2 cases].
    Vliers A; Stijns-Cailteux M; Lintermans J; Trémouroux-Wattiez M; Godfraind T
    Arch Mal Coeur Vaiss; 1984 May; 77(5):496-502. PubMed ID: 6428345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Calcium antagonists in heart failure?].
    Drexler H; Just H
    Klin Wochenschr; 1986 Oct; 64(20):993-1002. PubMed ID: 3784463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Calcium antagonists: pharmacological effects and therapeutic indications].
    Clozel JP; Théroux P; Caillé G; Bourassa MG
    Union Med Can; 1983 Mar; 112(3):236-40, 284. PubMed ID: 6344381
    [No Abstract]   [Full Text] [Related]  

  • 39. Calcium antagonist agents in hypertrophic cardiomyopathy.
    Chatterjee K
    Am J Cardiol; 1987 Jan; 59(3):146B-152B. PubMed ID: 3812266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium antagonist use in congestive heart failure: still a bridge too far?
    Piepho RW
    J Clin Pharmacol; 1995 May; 35(5):443-53. PubMed ID: 7657843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.